US2011160573A1PendingUtilityA1
Radiopaque Marking of Lead Electrode Zone in a Continuous Conductor Construction
Est. expiryOct 17, 2020(expired)· nominal 20-yr term from priority
A61N 1/0563
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A cardiac transvenous defibrillation lead has a continuous coil conductor within a layer of insulation. A portion of the coil conductor is exposed as a defibrillation electrode. In order to enhance fluoroscopic visualization of the exposed electrode during implant, the end of the exposed electrode is marked with a radiopaque element. The element may be in the form of an adhesive filled with radiopaque material that is used to backfill under the layer of insulation. Alternatively, a tube made of radiopaque material may be installed between the layer of insulation and the coil conductor.
Claims
exact text as granted — not AI-modified1 . A transvenous defibrillation lead, comprising:
a continuous coil conductor;
a layer of insulation over the coil conductor and providing for a distal portion of the coil conductor to be exposed as a defibrillation electrode; and
a body of adhesive filled with a radiopaque material positioned as a backfill under the insulation layer at a location adjacent the proximal end of the exposed defibrillation electrode.
2 . The lead of claim 1 wherein the radiopaque material is tantalum powder.
3 . The lead of claim 1 wherein the radiopaque material is barium sulfate.
4 . A method of marking a lead to distinguish portions of electrode and non-electrode segments of the lead after implant, the method comprising:
providing a layer of insulation over a continuous coil conductor; and providing a body of adhesive filled with a radiopaque material positioned as a backfill under the insulation layer at a location of the electrode segment.
5 . The method of claim 4 further comprising:
determining the position of said portions of the electrode segment in the heart based on the radiopaque marking.
6 . The method of claim 4 where said radiopaque marking is implemented to place at least one of said portions of the electrode segment in a specific zone of the heart for pacing and defibrillation procedures.
7 . The method of claim 4 wherein the radiopaque material is tantalum powder.
8 . The method of claim 4 wherein the radiopaque material is barium sulfate.Join the waitlist — get patent alerts
Track US2011160573A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.